Imaging IDs high-risk cardiac sarcoidosis patients

02/7/2014 | (free registration)

FDG-PET imaging showed that patients with established or possible cardiac sarcoidosis with irregular myocardial perfusion and tracer uptake, particularly in the right ventricle, were at higher risk of experiencing adverse events or death. Of 118 patients, 34 had abnormal readings for both metrics with a hazard ratio of 3.9 while those with RV uptake had a hazard ratio of 4.2, indicating a severe condition, according to details in the Journal of the American College of Cardiology. "Our study suggests that inflammation-targeted cardiac PET imaging has a potentially important role in evaluating patients with known or suspected cardiac sarcoidosis," researchers wrote.

View Full Article in: (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI